Manufacturing

Oct 30, 2017
By BioPharm International Editors
The biotechnology company has entered a contract with the United States Army to develop custom recombinant spider silk for protective textile applications.
Oct 27, 2017
By BioPharm International Editors
AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.
Oct 27, 2017
By BioPharm International Editors
As part of the $900-million deal, Incyte will pay $150 million upfront to develop and commercialize an anti-PD-1 drug candidate from biopharmaceutical company, MacroGenics.
Oct 25, 2017
By BioPharm International Editors
ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility.
Oct 25, 2017
By BioPharm International Editors
The M&A advisory firm has developed an interactive map of manufacturing sites to give insight into the market size of global manufacturing.
Oct 25, 2017
BioPharm International
The use of external retainers to enhance the seal between connectors and tubing is an essential component in single-use manufacturing systems.
Oct 24, 2017
By BioPharm International Editors
The API manufacturer has announced that it has completed the expansion of large-scale manufacturing capabilities at its Charles City, Iowa site.
Oct 24, 2017
By BioPharm International Editors
The biopharmaceutical company has received a $4.2-million grant from the Bill & Melinda Gates Foundation to invest in the development of new treatments for Enterotoxigenic Escherichia coli infections, a bacterial cause of diarrhea in the developing world.
Oct 23, 2017
By BioPharm International Editors
The biotechnology company has officially opened its new Michigan research and production center for the production of spider silk-based fibers, as well as for the company’s polymer research and development program.
Oct 23, 2017
By BioPharm International Editors
The clinical-stage biopharmaceutical company has announced the opening of a new gene therapy manufacturing facility in Modiin, Israel, which is anticipated to be the production site of the company’s lead cancer drug candidate.
native1_300x100
lorem ipsum